Correlations between psoriasis and inflammatory bowel diseases - PubMed (original) (raw)

Review

Correlations between psoriasis and inflammatory bowel diseases

Nevena Skroza et al. Biomed Res Int. 2013.

Abstract

For a long time the relationship between inflammatory bowel diseases (IBDs) and psoriasis has been investigated by epidemiological studies. It is only starting from the 1990s that genetic and immunological aspects have been focused on. Psoriasis and IBD are strictly related inflammatory diseases. Skin and bowel represent, at the same time, barrier and connection between the inner and the outer sides of the body. The most important genetic correlations involve the chromosomal loci 6p22, 16q, 1p31, and 5q33 which map several genes involved in innate and adaptive immunity. The genetic background represents the substrate to the common immune processes involved in psoriasis and IBD. In the past, psoriasis and IBD were considered Th1-related disorders. Nowadays the role of new T cells populations has been highlighted. A key role is played by Th17 and T-regs cells as by the balance between these two cells types. New cytokines and T cells populations, as IL-17A, IL-22, and Th22 cells, could play an important pathogenetic role in psoriasis and IBD. The therapeutic overlaps further support the hypothesis of a common pathogenesis.

PubMed Disclaimer

Figures

Figure 1

Similar articles

• Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
  Tillack C, Ehmann LM, Friedrich M, Laubender RP, Papay P, Vogelsang H, Stallhofer J, Beigel F, Bedynek A, Wetzke M, Maier H, Koburger M, Wagner J, Glas J, Diegelmann J, Koglin S, Dombrowski Y, Schauber J, Wollenberg A, Brand S. Tillack C, et al. Gut. 2014 Apr;63(4):567-77. doi: 10.1136/gutjnl-2012-302853. Epub 2013 Mar 6. Gut. 2014. PMID: 23468464
• Inflammatory eye, skin, and bowel disease in spondyloarthritis: genetic, phenotypic, and environmental factors.
  Brophy S, Pavy S, Lewis P, Taylor G, Bradbury L, Robertson D, Lovell C, Calin A. Brophy S, et al. J Rheumatol. 2001 Dec;28(12):2667-73. J Rheumatol. 2001. PMID: 11764216
• Psoriasis and Inflammatory Bowel Disease.
  Cottone M, Sapienza C, Macaluso FS, Cannizzaro M. Cottone M, et al. Dig Dis. 2019;37(6):451-457. doi: 10.1159/000500116. Epub 2019 May 10. Dig Dis. 2019. PMID: 31079092 Review.
• Psoriasis and erythema nodosum: two comorbidities of inflammatory bowel diseases.
  De Simone C, Sollena P, Coco V, Caldarola G. De Simone C, et al. G Ital Dermatol Venereol. 2013 Apr;148(2):175-84. G Ital Dermatol Venereol. 2013. PMID: 23588143 Review.
• Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis.
  Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Rizzello F, Gionchetti P. Cantini F, et al. J Rheumatol. 2017 Sep;44(9):1341-1346. doi: 10.3899/jrheum.161518. Epub 2017 Apr 15. J Rheumatol. 2017. PMID: 28412702

Cited by

• Association of Psoriasis With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
  Fu Y, Lee CH, Chi CC. Fu Y, et al. JAMA Dermatol. 2018 Dec 1;154(12):1417-1423. doi: 10.1001/jamadermatol.2018.3631. JAMA Dermatol. 2018. PMID: 30422277 Free PMC article.
• Ulcerative colitis induced by ixekizumab: a case report.
  Marin M, Alzueta N, Pío M, Gascón A, Castresana M. Marin M, et al. Eur J Hosp Pharm. 2021 Jan;28(1):50-52. doi: 10.1136/ejhpharm-2019-002016. Epub 2019 Oct 3. Eur J Hosp Pharm. 2021. PMID: 33355284 Free PMC article.
• Association between psoriasis, psoriatic arthritis and gastrointestinal disease : An exploratory nationwide inpatient sample analysis.
  Yousaf A, Raiker R, Davis SM, Gayam S, Zinn Z. Yousaf A, et al. Wien Klin Wochenschr. 2021 Jun;133(11-12):586-593. doi: 10.1007/s00508-020-01740-8. Epub 2020 Sep 23. Wien Klin Wochenschr. 2021. PMID: 32965553 Free PMC article.
• Crohn's-like disease in a patient exposed to anti-Interleukin-17 blockade (Ixekizumab) for the treatment of chronic plaque psoriasis: a case report.
  Smith MK, Pai J, Panaccione R, Beck P, Ferraz JG, Jijon H. Smith MK, et al. BMC Gastroenterol. 2019 Sep 5;19(1):162. doi: 10.1186/s12876-019-1067-0. BMC Gastroenterol. 2019. PMID: 31488067 Free PMC article.
• Biologics in Chronic Rhinosinusitis: An Update and Thoughts for Future Directions.
  Smith KA, Pulsipher A, Gabrielsen DA, Alt JA. Smith KA, et al. Am J Rhinol Allergy. 2018 Sep;32(5):412-423. doi: 10.1177/1945892418787132. Epub 2018 Jul 19. Am J Rhinol Allergy. 2018. PMID: 30021447 Free PMC article. Review.

References

1. 1. Rudikoff D, Baral J, Lebwohl M. Psoriasis and Crohn’s disease. The Mount Sinai Journal of Medicine. 1999;66(article 206) - PubMed
2. 1. Hoffmann R, Schieferstein G, Schunter F, Jenss H. Re: increased occurrence of psoriasis in patients with Crohn’s disease and their relatives. The American Journal of Gastroenterology. 1991;86(6):787–788. - PubMed
3. 1. Potenza C, Annetta A, Bernardini N, et al. Plaque Psoriasis: Anatomical, Clinical and Immunohistochemical Correlations During Anti-Tnfa Treatment. Vol. 1. Viareggio, Italy: J. Medical Books edizioni Srl; 2010.
4. 1. Hammer B, Ashurst P, Naish J. Diseases associated with ulcerative colitis and Crohn’s disease. Gut. 1968;9(1):17–21. - PMC - PubMed
5. 1. Yamamoto T, Yokoyama A. Coexistence of psoriasis vulgaris, ulcerative colitis, and thyroid adenoma. Journal of Dermatology. 1997;24(4):275–276. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Hindawi Limited
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal